Detail akcie CryoLife online

Business Summary: Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Artivion Inc revenues increased 13% to $354M. Net loss applicable to common stockholders increased 60% to $30.6M. Revenues reflect Medical devices segment increase of 13% to $261.2M, Preservation services segment increase of 11% to $92.8M, International segment increase of 14% to $174.5M, United States segment increase of 11% to $179.5M.